Core Viewpoint - Aerospace Changfeng's stock price experienced a significant decline, with a cumulative drop of 20% over three consecutive trading days, triggering an abnormal trading price fluctuation notice [1] Group 1: Stock Performance - The company's stock trading on January 13, 14, and 15, 2026, showed a cumulative closing price drop of 20%, which is classified as an abnormal fluctuation according to the Shanghai Stock Exchange trading rules [1] Group 2: Company Operations - The company conducted a self-examination and consulted with its controlling shareholder and actual controller, confirming that there are no undisclosed significant information apart from what has already been disclosed [1] - The company's main business segments include military electronics, public safety, and high-end medical equipment, with no significant changes in its main business, daily operations, or operating environment compared to previously disclosed information [1]

Core Viewpoint - Aerospace Changfeng's stock price has experienced a significant increase of 65.95% over a 12-day trading period from December 24, 2025, to January 12, 2026, indicating potential risks of a price correction in the near future [1] Business Segments - The company operates in three main business segments: military electronics, public safety, and high-end medical equipment [1] - Currently, the company has not engaged in brain-computer interface technologies or commercial aerospace-related businesses [1]

Group 1 - The core business of the company is divided into three main sectors: military electronics, public safety, and high-end medical equipment [1] - The company does not engage in commercial aerospace or related businesses [1]